A UK-based startup looks to beat Spark’s Luxturna at its own game with programmable cell platform for eye disease

· by · in Biotechnology industry, iPS Cells, Personalized Therapies, Regenerative Medicine. ·


Darrin Disley (L) and Pierre-Louis Joffrin
https://endpts.com/a-uk-based-startup-looks-to-beat-sparks-luxturna-at-its-own-game-with-programmable-cell-platform-for-eye-disease/

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.